UK markets closed

Day One Biopharmaceuticals, Inc. (DAWN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
17.17-0.40 (-2.28%)
At close: 04:00PM EDT
17.25 +0.08 (+0.47%)
After hours: 04:38PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts881010
Avg. Estimate-0.66-0.67-2.62-1.91
Low estimate-0.71-0.78-2.89-2.78
High estimate-0.63-0.56-2.29-1.13
Year ago EPS-0.59-0.61-2.37-2.62
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts681111
Avg. EstimateN/A890k12.36M80.02M
Low estimateN/AN/A3.4M15.1M
High estimateN/A2.5M21.3M135.23M
Year ago salesN/AN/AN/A12.36M
Sales growth (year/est)N/AN/AN/A547.40%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.59-0.61-0.6-0.58
Actual EPS-0.59-0.61-0.54-0.64
Difference000.06-0.06
Surprise %0.00%0.00%10.00%-10.30%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.66-0.67-2.62-1.91
7 days ago-0.66-0.67-2.62-1.91
30 days ago-0.66-0.67-2.62-2.01
60 days ago-0.66-0.67-2.58-2.01
90 days ago-0.6-0.6-2.24-1.47
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/A115
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesDAWNIndustrySector(s)S&P 500
Current qtr.-11.90%N/AN/AN/A
Next qtr.-9.80%N/AN/AN/A
Current year-10.50%N/AN/AN/A
Next year27.10%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A